TAK-593

Tak-593 holds potential applications primarily in oncology, particularly for:

• Cancer Treatment: As a therapeutic agent targeting solid tumors through its anti-angiogenic properties.
• Research Tool: It serves as a valuable tool in studying angiogenesis and tumor biology due to its specificity and potency against key signaling pathways involved in cancer progression.

Tak-593 exhibits significant biological activity characterized by:

• Inhibition of Angiogenesis: It effectively inhibits VEGF-induced tube formation in endothelial cells, a critical process in angiogenesis.
• Anti-tumor Effects: In vivo studies have shown that Tak-593 reduces tumor vessel permeability and exhibits anti-tumor activity in xenograft models of lung carcinoma.
• Selectivity: The compound shows high selectivity for VEGFR2 and PDGFRβ, minimizing off-target effects commonly associated with less selective inhibitors.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.